Introduction Although statin therapy is a powerful lipid-lowering strategy, only one-fifth of
statin users currently reach their lipid goals. In addition, statin treatment alone has relatively …

Introduction: Statins are powerful lipid-lowering agents which reduce cardiovascular (CV)–
related morbidity and mortality. However, a large proportion of patients cannot attain the …

Cardiovascular disease is one of the leading causes of death around the world with various
efforts being made to reduce risk in patients through preventive measures. One major …

Purpose The aim of this study was to evaluate the safety and efficacy of combination
treatment of rosuvastatin with ezetimibe in patients with primary hypercholesterolemia …

Objective: Results of direct comparative studies between ezetimibe/simvastatin and
rosuvastatin therapies have not been reported. Both of these treatment options offer …

Introduction: Reducing low-density lipoprotein cholesterol (LDL-C) with lipid-lowering
therapies has been associated with a decrease in the frequency of cardiovascular events …

Background Statins are used to treat hypercholesterolemia in patients with type 2 diabetes
mellitus, but many of these patients fail to achieve the target LDL-C level. Recent reports …

Purpose The goal of this study was to compare the lipid-lowering efficacy of the combination
of ezetimibe and low-or intermediate-intensity statin therapy versus that of high-intensity …

Hyperlipidaemia is a pivotal risk factor for the development of atherosclerotic disease. A
large number of studies have demonstrated that the treatment of abnormalities in lipoprotein …

Aim We aimed to compare the effects of fixed‐dose combinations of ezetimibe plus
rosuvastatin to rosuvastatin alone in patients with primary hypercholesterolemia, including a …